SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane
0 references·16 citing·40 second hopsampled
Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane (1998)Confidence intervals or surfaces? Uncerta…How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3) (2016)How to prepare a systematic r…Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan (2016)Development of an Official Gu…The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions (2014)The Influence of Cost‐Effecti…Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Regression models for analyzi…Population based screening for chronic kidney disease: cost effectiveness study (2010)Population based screening fo…Non‐parametric methods for cost‐effectiveness analysis: the central limit theorem and the bootstrap compared (2009)Non‐parametric methods for co…Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope (2006)Using the net benefit regress…Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation (2006)Using and interpreting cost-e…Statistical Analysis of Cost‐effectiveness Data (2006)Statistical Analysis of Cost‐…Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making (2003)Use of Pharmacoeconomics Info…Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data (2003)Regression methods for covari…Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies (2003)Advantages of Using the Net-B…Opportunity costs and uncertainty in the economic evaluation of health care interventions (2002)Opportunity costs and uncerta…Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses (2001)Quantifying stochastic uncert…Definition, interpretation and calculation of cost-effectiveness acceptability curves (2000)Definition, interpretation an…A Bayesian approach to stochastic cost-effectiveness analysis (1999)A Bayesian approach to stocha…Costs, effects and C/E‐ratios alongside a clinical trial (1994)Net Health Benefits (1998)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Economic evaluation of a task-shifting intervention for common mental disorders in India (2012)Health economic evaluation: Important principles and methodology (2013)Hedonic Prices and Implicit Markets: Product Differentiation in Pure Competition (1974)National Institute for Clinical Excellence and its value judgments (2004)The NICE Cost-Effectiveness Threshold (2008)CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? (2014)Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness (2015)Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L (2018)ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL (1996)Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods (2002)Alternative to Mental Hospital Treatment (1980)Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) (1987)Cost-Effectiveness in Health and Medicine (1996)Methods for incorporating covariate adjustment, subgroup analysis and between‐centre differences into cost‐effectiveness evaluations (2005)Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation (1997)BAYESIAN VALUE-OF-INFORMATION ANALYSIS (2001)Incremental cost-effectiveness ratios (ICERs): The silence of the lambda (2005)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Cost-effectiveness of chronic kidney disease mass screening test in Japan (2011)Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study (2012)Cost-effectiveness of screening for chronic kidney disease in the general adult population: a systematic review (2023)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3) (2016)Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review (2020)Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report (2021)Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions (2013)The effectiveness of 6 versus 12-months of dialectical behaviour therapy for borderline personality disorder: the feasibility of a shorter treatment and evaluating responses (FASTER) trial protocol (2018)Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial (2022)The Value of Value of Information (2010)Does internet-based cognitive behaviour therapy reduce healthcare costs and resource use in treatment of social anxiety disorder? A cost-minimisation analysis conducted alongside a randomised controlled trial (2017)Cost-effectiveness of a blended physiotherapy intervention compared to usual physiotherapy in patients with hip and/or knee osteoarthritis: a cluster randomized controlled trial (2018)Does equity in healthcare spending exist among Indian states? Explaining regional variations from national sample survey data (2017)Global treatment costs of breast cancer by stage: A systematic review (2018)Determinants of healthcare seeking and out-of-pocket expenditures in a “free” healthcare system: evidence from rural Malawi (2020)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

No references inside the corpus for this window.

Cited by

  • 2003Regression methods for covariate adjustment and subgroup analysis for non‐censored cost‐effectiveness data363 cited
  • 2000Definition, interpretation and calculation of cost-effectiveness acceptability curves292 cited
  • 2006Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation279 cited
  • 1999A Bayesian approach to stochastic cost-effectiveness analysis253 cited
  • 2014The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions232 cited
  • 2016How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3)220 cited
  • 2009Non‐parametric methods for cost‐effectiveness analysis: the central limit theorem and the bootstrap compared188 cited
  • 2011Regression models for analyzing costs and their determinants in health care: an introductory review176 cited
  • 2006Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope163 cited
  • 2010Population based screening for chronic kidney disease: cost effectiveness study160 cited
  • 2006Statistical Analysis of Cost‐effectiveness Data155 cited
  • 2016Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

154 cited
  • 2003Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making131 cited
  • 2003Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies124 cited
  • 2002Opportunity costs and uncertainty in the economic evaluation of health care interventions115 cited
  • 2001Quantifying stochastic uncertainty and presenting results of cost-effectiveness analyses112 cited